Vaccine Development Related News
World first COVID-19 smart vaccine patch
In a world first development, researchers are creating a COVID-19 smart vaccine patch that will deliver the vaccine as well as measure its efficacy.
The...
Oxford University COVID-19 vaccine roll out begins
The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today.
The...
European Commission concludes Novavax talks for COVID-19 vaccine
The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine.
The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK
Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
AstraZeneca to test component of Russia’s Sputnik V vaccine
AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus.
Following the preliminary...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
One step closer to a COVID-19 vaccine for the UK
Pfizer and BioNTech SE have announced their mRNA-based COVID-19 vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of infection.
The...
New UK laws allow healthcare workers to administer vaccines
Changes to the Human Medicine Regulations 2012 have now come into force in the UK, with new laws which will allow healthcare workers to...
Are T cells key to controlling COVID-19 and reducing its severity?
A new study has confirmed that T cells play an important role in the body’s response to COVID-19.
The findings show that a multi-layered, virus-specific...
UK secures access to 90 million doses of potential COVID-19 vaccine
The UK Government has today announced it has secured early access to 90 million doses of a potential COVID-19 vaccine.
Announced by Business Secretary Alok...
New EU approved flu vaccine is designed to protect over 65’s
The European Commission has given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe and is designed to protect...
WHO: reducing disease inequality with vaccine funding
The World Health Organization has welcomed crucial new funding for vaccines across the globe that it says will help in the fight against COVID-19,...
Coronavirus Global Response campaign aims for affordable vaccine for all
The European Commission’s Coronavirus Global Response campaign has teamed up with Global Citizen to launch the next phase of the campaign that aims to...
New microneedle vaccine could expand global immunisation capabilities
A new microneedle vaccine delivery system has been developed that has the potential to improve cellular immune responses in patients and expand global immunisation...
The Wellcome Trust’s battle to turn COVID-19 to COVID-Zero
COVID-19 is a global crisis – but a solvable one. The Wellcome Trust is inviting businesses to donate a percentage of funds to help...
Research shows how to boost immune responses to vaccines in seniors
New research has shown how older people’s immune system response to vaccines could be boosted using immunology expertise and the surprising use of genital...
Horizon 2020 collaboration to develop COVID-19 vaccine
OPENCORONA consortium has been awarded €3m funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak, aiming to develop a...
Stem cells: what do bones have to do with boosting immunity?
A newly discovered memory that is stored in our bones has revealed the surprising role of stem cells in boosting our immunity.
A research team...
Ebola vaccine authorised by European Commission
The European Commission has granted its first ever marketing authorisation for a vaccine protecting patients against Ebola.
The Commission has adopted a decision granting authorisation...
Oral cholera vaccine: IVI awarded $4.5 million grant to increase accessibility
The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to increase accessibility of oral cholera...